Consensus Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse Other stock markets 01:30:02 27/04/2024 am IST			5-day change	1st Jan Change
18.55 ^USD	+0.71%		+4.10%	+28.64%

09/04	Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating	MT
08/04	Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint	MT

Evolution of the average Target Price on Organon & Co.

Price target over the last 5 years

History of analyst recommendation changes

d91.Iteg-1V_cr5BbIF154yUsVD8jHBkzZiTg5gJ9N1YgSU.cob4gTs8OY8THvsArN38gB6y4AAui63V-dUxsIJs1BcXjtqcIBMB2QoF6g~e0650ef66a98cd776f390cc31bef0445

Analyst Recommendations on Organon & Co.

Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating	09/04	MT
Goldman Sachs Adjusts Price Target on Organon to $18 From $16, Keeps Neutral Rating	20/02	MT
Piper Sandler Adjusts Organon & Co.'s Price Target to $22 From $32, Maintains Overweight Rating	22/11	MT
Goldman Sachs Downgrades Organon to Neutral From Buy, Cuts Price Target to $16 From $33	03/11	MT
Morgan Stanley Adjusts Price Target on Organon to $22 From $27, Maintains Equal-Weight Rating	11/23/11	MT
Barclays Initiates Organon With Overweight Rating, Price Target is $28	21/23/21	MT
Morgan Stanley Adjusts Price Target on Organon to $27 From $25, Maintains Equal-Weight Rating	09/23/09	MT
Morgan Stanley Cuts Price Target on Organon to $25 From $26, Maintains Equal-Weight Rating	08/23/08	MT
Raymond James Starts Organon & Co. at Outperform With $33 Price Target	16/23/16	MT
Hot Wholesale Prices Print Saps Appetite for US Equities as Concern Mounts Rates Headed Higher	16/23/16	MT
Marketmind: Growth trumps rates	16/23/16	RE
Morgan Stanley Lowers Price Target for Organon to $24 From $27, Keeps Equalweight Rating	04/22/04	MT
BofA Securities Downgrades Organon to Underperform From Neutral, Adjusts Price Target to $25 From $37	14/22/14	MT
Morgan Stanley Lowers Organon & Co's Price Target to $27 From $35, Maintains Equalweight Rating	12/22/12	MT
Piper Sandler Upgrades Organon & Co. to Overweight From Neutral, Adjusts Price Target to $34 From $37	06/22/06	MT
Goldman Sachs Trims Organon & Co's Price Target to $38 From $41, Keeps Buy Rating	08/22/08	MT
BofA Securities Downgrades Organon to Neutral From Buy, Adjusts Price Target to $37 From $40	05/22/05	MT
Goldman Sachs Adjusts Price Target for Organon & Co to $41 From $42, Maintains Buy Rating	19/22/19	MT
Morgan Stanley Trims Organon & Co's Price Target to $34 From $35, Maintains Equalweight Rating	08/22/08	MT
Goldman Sachs Starts Organon & Co. at Buy With $40 Price Target	27/22/27	MT
Morgan Stanley Adjusts Organon & Co.'s Price Target to $35 from $37, Keeps Equalweight Rating	06/22/06	MT
Morgan Stanley Adjusts Organon & Co Price Target to $37 From $35, Maintains Equalweight Rating	23/22/23	MT
ORGANON : Piper Sandler Starts Organon at Neutral With $35 Price Target	07/21/07	MT
ORGANON : BofA Securities Starts Organon & Co. at Buy with $43 Price Target	01/21/01	MT
ORGANON : Citigroup Adjusts Organon's Price Target to $43 From $35, Reiterates Buy Rating	18/21/18	MT